Qube Research & Technologies (QRT)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4K | Buy |
+39,036
| New | +$35.4K | ﹤0.01% | 2415 |
|
|
2024
Q3 | – | Sell |
-68,286
| Closed | -$68.1K | – | 3231 |
|
|
2024
Q2 | $68.1K | Buy |
68,286
+55,163
| +420% | +$55K | ﹤0.01% | 2310 |
|
|
2024
Q1 | $19.4K | Buy |
+13,123
| New | +$19.4K | ﹤0.01% | 3183 |
|
|
2023
Q2 | – | Sell |
-221,946
| Closed | -$333K | – | 2635 |
|
|
2023
Q1 | $333K | Buy |
221,946
+84,378
| +61% | +$127K | ﹤0.01% | 1649 |
|
|
2022
Q4 | $161K | Buy |
137,568
+34,246
| +33% | +$40.1K | ﹤0.01% | 1812 |
|
|
2022
Q3 | $117K | Buy |
103,322
+13,362
| +15% | +$15.1K | ﹤0.01% | 1878 |
|
|
2022
Q2 | $142K | Buy |
+89,960
| New | +$142K | ﹤0.01% | 1806 |
|
|
2021
Q2 | – | Sell |
-191,483
| Closed | -$450K | – | 2553 |
|
|
2021
Q1 | $450K | Buy |
191,483
+3,519
| +2% | +$8.27K | 0.01% | 1233 |
|
|
2020
Q4 | $331K | Buy |
187,964
+91,260
| +94% | +$161K | ﹤0.01% | 1303 |
|
|
2020
Q3 | $91K | Sell |
96,704
-38,434
| -28% | -$36.2K | ﹤0.01% | 1500 |
|
|
2020
Q2 | $118K | Buy |
+135,138
| New | +$118K | ﹤0.01% | 1491 |
|